Albert Bourla, Pfizer CEO (Steven Ferdman/Getty Images)
October 12, 2020 07:22 AM EDT
Coronavirus

Covid-19 roundup: Pfiz­er strikes vac­cine deal with New Zealand, as CEO Al­bert Bourla de­fends de­vel­op­ment rush to crit­ics

Nicole DeFeudis

Editor

Pfiz­er and BioN­Tech have inked a deal with New Zealand for 1.5 mil­lion vac­cine dos­es to be de­liv­ered as ear­ly …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Bio­gen of­fers to buy out strug­gling neu­ro part­ner Sage Ther­a­peu­tics

Chas­ing the next wave of obe­si­ty drugs, Met­sera files for an IPO

Ex­clu­sive: Mod­er­na's for­mer top sci­en­tist has a new start­up us­ing AI to im­prove mR­NA ther­a­pies

Four biotechs emerge with $800M and in-li­censed as­sets on Fri­day

Post-Hoc: Big Phar­ma is los­ing the AI tal­ent war

Up­dat­ed: CDER Di­rec­tor Pa­trizia Cavaz­zoni to step down ahead of Trump pres­i­den­cy

A service from the Financial Times